Skip to main content
TipRanks
Go Ultimate75% OFF

IMPACT Therapeutics, Inc. Class H (7630) Revenue

IMPACT Therapeutics, Inc. Class H Revenue

IMPACT Therapeutics, Inc. Class H had a revenue of 15.31M in the quarter ending Jun 30, 2026, with 736.69%. This bring the company's revenue in the last twelve months to 17.14M, Increased 224.49%. In the fiscal year ending Dec 31, 2025, IMPACT Therapeutics, Inc. Class H had annual revenue of 5.33M with 13.86% growth.

Revenue (ttm)
17.14M
Revenue Growth
394.93%
P/S Ratio
461.93
Revenue/Employee
HKD 60,557
Employees
88
Market Cap
HKD 2.46B

Revenue Chart

IMPACT Therapeutics, Inc. Class H Revenue - Annual

010M20M30M40M33.27M4.68M5.33M202320242025
Revenue History
Download to Excel
HK:7630 revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20255.33M648.64K13.86%
Dec 31, 20244.68M-28.59M-85.93%
Dec 31, 202333.27M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
HK:763017.14M
HK:1672947.00K
HK:61851.25B
HK:9887231.45M
HK:2595―
HK:1779―